Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000110

Director sold 99 shares at an average $1,085.53 ($107,467)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

RYAN ARTHUR F · Director

Table I: Non-derivative

30 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-01 Sale : show line 1 in the form 10b5-1 −1 $1,053.22 $1,053 17,881 D
2024-08-01 Sale : show line 2 in the form 10b5-1 −1 $1,058.90 $1,059 17,880 D
2024-08-01 Sale : show line 3 in the form 10b5-1 −1 $1,062.71 $1,063 17,879 D
2024-08-01 Sale : show line 4 in the form 10b5-1 −6 $1,065.39 $6,392 17,873 D
2024-08-01 Sale : show line 5 in the form 10b5-1 −4 $1,066.33 $4,265 17,869 D
2024-08-01 Sale : show line 6 in the form 10b5-1 −1 $1,067.53 $1,068 17,868 D
2024-08-01 Sale : show line 7 in the form 10b5-1 −1 $1,068.08 $1,068 17,867 D
2024-08-01 Sale : show line 8 in the form 10b5-1 −4 $1,070.46 $4,282 17,863 D
Open-market sales · 99 sh · avg $1,085.53 · $107,467
Loading xslF345X05/edgardoc.xml…